Page 13 - kpiebook65064

The Synthesis of Policy recommendations for promoting Good

Pharmaceutical Governance has two objectives. First, the report analyzes the risk of
Good Governance in Pharmaceutical System in Thailand and, second, proposes the

policy recommendation for strengthening Good Pharmaceutical Governance in Thailand
due to Pharmaceutical Governance should be developed in three targets; First,
Pharmaceutical Governance must provide the medicines that have qualities and coverage

for treatments; Second, Pharmaceutical Governance must spends effectively the public
budgets and; Third, Pharmaceutical Governance must be deprives of the corruptions.

Furthermore, the report uses Good Governance Framework for analysis that consists of
Rule of Law, Transparency, Accountability, Participation and Efficiency.

The scope of study of Pharmaceutical Governance in this report focuses on three

procedures. First, Drug Registrations are operated by Food and Drug Administration
Thailand (Thai-FDA) that officiate about consultations, verifications and permits all
medicinal licenses for imports and manufacturing in Thailand. Second, Drug Selection is

operated by Sub?committee on Development of the Essential Drugs List who selects
National List of Essential Medicines (NLEM). Third, Public Procurement for medicines is

operated by public hospitals that regulate by Ministry of Public Health (MoPH).

The results of study discover the risk of Good Governance in Pharmaceutical
Governance in three procedures.

1. The risk of Drug Registrations consists of (1) The uncover and obsolete of

Pharmacy Act 1967, (2) The appointment and operation of Medicinal
Committee, (3) The conflict of Interests of the members of Medicinal

Committee and experts, (4) The lack of Experts who verify the documentary